XML 46 R36.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurement (Tables)
6 Months Ended
Jun. 30, 2021
Summary of Financial Items Carried at Fair Value
Financial items carried at fair value on a recurring basis as of June 30, 2021 and December 31, 2020 are classified in the tables below in one of the three categories of fair value levels:
 
    
June 30, 2021
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
    
(U.S. $ in millions)
 
Cash and cash equivalents:
                                   
Money markets
   $ 278      $ —        $ —        $ 278  
Cash, deposits and other
     2,158        —          —          2,158  
Investment in securities:
                                   
Equity securities*
     35        —          —          35  
Other, mainly debt securities
     5        —          1        6  
Derivatives:
                                   
Asset derivatives—options and forward contracts
     —          30        —          30  
Liability derivatives—options and forward contracts
     —          (25      —          (25
Contingent consideration**
     —          —          (205      (205
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 2,476      $ 5      $ (204    $ 2,277  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
    
December 31, 2020
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
    
(U.S. $ in millions)
 
Cash and cash equivalents:
                                   
Money markets
   $ 367      $ —        $ —        $ 367  
Cash, deposits and other
     1,810        —          —          1,810  
Investment in securities:
                                   
Equity securities*
     25        259        —          284  
Other, mainly debt securities
     5        —          10        15  
Derivatives:
                                   
Asset derivatives—options and forward contracts
     —          24        —          24  
Liability derivatives—options and forward contracts
     —          (79      —          (79
Contingent consideration**
     —          —          (268      (268
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 2,207      $ 204      $ (258    $ 2,153  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
*
During the first quarter of 2021, Teva’s shares in American Well Corporation (“American Well”) moved from a Level 2 measurement to a Level 1 measurement within the fair value hierarchy, since they are no longer subject to a sale restriction. As of June 30, 2021, Teva sold most of its holdings in American Well, and subsequently sold its remaining holdings.
**
Contingent consideration represents liabilities recorded at fair value in connection with acquisitions.
Summary of Fair Value of Financial Liabilities Measured Using Level 3 Inputs
The following table summarizes the activity for those financial assets and liabilities where fair value measurements are estimated utilizing Level 3 inputs:
 
    
Six months ended
June 30, 2021
    
Six months ended
June 30, 2020
 
    
(U.S. $ in millions)
 
Fair value at the beginning of the period
   $ (258      (448
Redemption of debt securities
     (9      —    
Revaluation of debt securities
     —          1  
Adjustments to provisions for contingent consideration:
                 
Actavis Generics transaction
     22        (15
Eagle transaction
     (7      (67
Settlement of contingent consideration:
                 
Eagle transaction
     48        58  
    
 
 
    
 
 
 
Fair value at the end of the period
   $ (204    $ (471
Summary of Financial Instrument Measured on a Basis Other Than Fair Value
Financial instruments measured on a basis other than fair value mostly consist of senior notes and convertible senior debentures (see note 7) and are presented in the table below in terms of fair value (level 1 inputs):
 
    
Estimated fair value*
 
    
June 30,
    
December 31,
 
    
2021
    
2020
 
    
(U.S. $ in millions)
 
Senior notes included under senior notes and loans
  
$
21,449
 
  
$
22,684
 
Senior notes and convertible senior debentures included under short-term debt
  
 
3,548
 
  
 
3,207
 
    
 
 
    
 
 
 
Total
  
$
24,997
 
  
$
25,891
 
    
 
 
    
 
 
 
 
*
The fair value was estimated based on quoted market prices.